PACS Group executive Murray Jason Hulse sold 68,113 shares in transactions priced between $42.35 and $43.36 per share. After the transactions, Hulse owned 54,626,753 PACS Group shares, giving investors the disclosed post-sale ownership figure alongside the executive’s reported share sales.
Key Highlights
- PACS Group shares changed hands at prices ranging from $42.35 to $43.36 per share.
- Murray Jason Hulse owned 54,626,753 PACS Group shares after the transactions.
- Murray Jason Hulse sold 68,113 PACS Group shares.
PACS Group, Inc. (NYSE: PACS) Co-Founder, CEO & Chairman Murray Jason Hulse sold 68,113 shares in transactions involving PACS Group stock. The filing reports Hulse’s sales and his ownership following the transactions.
PACS Group Executive Sale Details
The transactions took place between 1 September 2026 and 3 September 2026. Prices ranged from $42.35 to $43.36 per share across the reported transactions. The highest reported price was $43.36 per share, while the lowest was $42.35 per share. Following the transactions, Hulse owned 54,626,753 PACS Group shares.
FAQs
Q: How many PACS Group shares did Murray Jason Hulse sell?
A: Murray Jason Hulse sold 68,113 PACS Group shares. The transactions were reported at prices ranging from $42.35 to $43.36 per share.
Q: What happened to PACS Group executive ownership after the sale?
A: Following the reported transactions, Murray Jason Hulse owned 54,626,753 PACS Group shares. The filing identifies Hulse as the company’s co-founder, CEO and chairman.
Q: When did the PACS Group stock transactions occur?
A: The six reported PACS Group transactions occurred between 1 September 2026 and 3 September 2026. The filing states that each transaction used SEC transaction code S.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.